97-9240. Submission for OMB Review; Comment Request; Clinical, Laboratory, and Epidemiologic Characterization of Individuals at High Risk of Cancer  

  • [Federal Register Volume 62, Number 69 (Thursday, April 10, 1997)]
    [Notices]
    [Page 17626]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-9240]
    
    
    
    [[Page 17626]]
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    Submission for OMB Review; Comment Request; Clinical, Laboratory, 
    and Epidemiologic Characterization of Individuals at High Risk of 
    Cancer
    
    SUMMARY: Under the provisions of Section 3506(c)(2)(A) of the Paperwork 
    Reduction Act of 1995, the National Cancer Institute (NCI), the 
    National Institutes of Health (NIH) has submitted to the Office of 
    Management and Budget (OMB) a request to review and approve the 
    information collection listed below. This proposed information 
    collection was previously published in the Federal Register on December 
    16, 1996, pages 66052-66053 and allowed 60 days for public comment. 
    Only one comment from the public was received; it was a request for 
    additional information about the project. The purpose of this notice is 
    to allow an additional 30 days for public comment. The National 
    Institutes of Health may not conduct or sponsor, and the respondent is 
    not required to respond to, an information collection that has been 
    extended, revised, or implemented on or after October 1, 1995, unless 
    it displays a currently valid OMB control number.
    
    PROPOSED COLLECTION:
    
        Title: Clinical, Laboratory, and Epidemiologic Characterization of 
    Individuals at High Risk of Cancer. Type of Information Collection 
    Request: Extension of OMB No. 0925-0194 (Expiration date 04/30/97). 
    Need and Use of Information Collection: This ongoing research study 
    will identify cancer-prone persons in order to learn about cancer risk 
    and cancer causes in individuals and families. The primary objectives 
    of this research study are to utilize clinical, laboratory, and 
    epidemiologic approaches in studies of individuals and families at high 
    risk of cancer to identify and further characterize cancer 
    susceptibility factors. Respondents are members of families in which 
    multiple cancers are thought to have occurred. Information about the 
    occurrence of cancer is collected and reviewed to determine eligibility 
    for further etiologic study. Participation is entirely voluntary. The 
    findings will lead to a better understanding of the causes and risk 
    factors for selected cancers, which may reduce cancer incidence, and 
    promote the earlier diagnosis of some cancers. Frequency of Response: 
    One time. Affected Public: Individuals or households. Type of 
    Respondents: Adults. The annual reporting burden is as follows: 
    Estimated Number of Respondents: 600 per year; Estimated Number of 
    Responses per Respondent: 1; Average Burden Hours Per Response: .75; 
    and Estimated Total Annual Burden Hours Requested: 450. The annualized 
    cost to respondents is estimated at $4,500. There are no Capital Costs 
    to report. There are no Operating or Maintenance Costs to report.
    
    Request for Comments
    
        Written comments and/or suggestions from the public and affected 
    agencies are invited on one or more of the following points: (1) 
    Whether the proposed collection of information is necessary for the 
    proper performance of the function of the agency, including whether the 
    information will have practical utility; (2) The accuracy of the 
    agency's estimate of the burden of the proposed collection of 
    information, including the validity of the methodology and assumptions 
    used; (3) Ways to enhance the quality, utility, and clarity of the 
    information to be collected; and (4) Ways to minimize the burden of the 
    collection of information on those who are to respond, including the 
    use of appropriate automated, electronic, mechanical, or other 
    technological collection techniques or other forms of information 
    technology.
    
    Direct Comments to OMB
    
        Written comments and/or suggestions regarding the item(s) contained 
    in this notice, especially regarding the estimated public burden and 
    associated response time, should be directed to the: Office of 
    Management and Budget, Office of Regulatory Affairs, New Executive 
    Office Building, Room 10235, Washington, D.C. 20503, Attention: Desk 
    Officer for NIH. To request more information on the proposed project or 
    to obtain a copy of the data collection plans and instruments, contact: 
    Dr. Margaret Tucker, Chief, Genetic Epidemiology Branch, National 
    Cancer Institute, NIH, Executive Plaza North, Room 439, 6130 Executive 
    Blvd., Bethesda, MD 20892, or call non-toll-free number (301) 496-4375, 
    or E-mail your request, including your address to: 
    tuckerp@epndce.nci.nih.gov.
    
    COMMENTS DUE DATE: Comments regarding this information collection are 
    best assured of having their full effect if received on or before May 
    12, 1997.
    
        Dated: April 1, 1997.
    Nancie L. Bliss,
    OMB Project Clearance Liaison.
    [FR Doc. 97-9240 Filed 4-9-97; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
5/12/1997
Published:
04/10/1997
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
97-9240
Dates:
Comments regarding this information collection are best assured of having their full effect if received on or before May 12, 1997.
Pages:
17626-17626 (1 pages)
PDF File:
97-9240.pdf